Alector to Present at the Stifel 2021 Virtual Healthcare Conference
09 November 2021 - 8:05AM
Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology
company pioneering immuno-neurology, today announced
that Arnon Rosenthal, Ph.D., Chief Executive Officer of
Alector, will participate in a fireside chat at
the Stifel 2021 Virtual Healthcare
Conference on Monday, November 15, 2021, at 2:00
p.m. ET.
A live webcast of the fireside chat will be available on the
“Events & Presentations” page within the Investors section of
the Alector website at http://investors.alector.com. A replay
will be available on the Alector website for 90 days following the
event.
About Alector
Alector is a clinical-stage biotechnology company
pioneering immuno-neurology, a novel therapeutic approach for the
treatment of neurodegenerative diseases. Immuno-neurology
targets immune dysfunction as a root cause of multiple pathologies
that are drivers of degenerative brain disorders. Alector has
discovered and is developing a broad portfolio of innate immune
system programs, designed to functionally repair genetic mutations
that cause dysfunction of the brain’s immune system and enable the
rejuvenated immune cells to counteract emerging brain pathologies.
Alector’s immuno-neurology product candidates are supported by
biomarkers and target genetically defined patient populations in
frontotemporal dementia and Alzheimer’s disease. This scientific
approach is also the basis for the company’s immuno-oncology
programs. Alector is headquartered in South San Francisco,
California. For additional information, please
visit www.alector.com.
Contacts
1ABDan Budwick973-271-6085dan@1abmedia.com
or
Investors:Alector, Inc.ir@alector.com
Alector (NASDAQ:ALEC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Alector (NASDAQ:ALEC)
Historical Stock Chart
From Apr 2023 to Apr 2024